Matin M Imanguli

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. ncbi Chronic graft versus host disease of oral mucosa: review of available therapies
    Matin M Imanguli
    National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101:175-83. 2006
  2. ncbi Myofibroblastic tumor of the lower lip in a patient with X-linked hypogammaglobulinemia and isolated growth hormone deficiency: a case report
    Matin M Imanguli
    Clinical Research Cores, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA
    J Oral Maxillofac Surg 65:1219-22. 2007
  3. pmc Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation
    Matin M Imanguli
    Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Biol Blood Marrow Transplant 16:1362-9. 2010
  4. pmc Increased T-bet+ cytotoxic effectors and type I interferon-mediated processes in chronic graft-versus-host disease of the oral mucosa
    Matin M Imanguli
    Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Blood 113:3620-30. 2009
  5. pmc Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation
    Matin M Imanguli
    Clinical Research Core, National Institutes of Health, Bethesda, MD 20892, USA
    Exp Hematol 35:184-92. 2007

Detail Information

Publications5

  1. ncbi Chronic graft versus host disease of oral mucosa: review of available therapies
    Matin M Imanguli
    National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod 101:175-83. 2006
    ..Available evidence for efficacy and safety of various systemic and topical agents, including corticosteroids, calcineurin antagonists, mycophenolate mofetil, and extracorporeal photopheresis, is reviewed...
  2. ncbi Myofibroblastic tumor of the lower lip in a patient with X-linked hypogammaglobulinemia and isolated growth hormone deficiency: a case report
    Matin M Imanguli
    Clinical Research Cores, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892, USA
    J Oral Maxillofac Surg 65:1219-22. 2007
  3. pmc Salivary gland involvement in chronic graft-versus-host disease: prevalence, clinical significance, and recommendations for evaluation
    Matin M Imanguli
    Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Biol Blood Marrow Transplant 16:1362-9. 2010
    ..Formal evaluation of salivary function using standardized criteria is needed, and this could be incorporated as an outcome measure in clinical trials of cGVHD...
  4. pmc Increased T-bet+ cytotoxic effectors and type I interferon-mediated processes in chronic graft-versus-host disease of the oral mucosa
    Matin M Imanguli
    Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Blood 113:3620-30. 2009
    ..The clinical trials are registered at http://www.clinicaltrials.gov as NCT00331968...
  5. pmc Changes in salivary proteome following allogeneic hematopoietic stem cell transplantation
    Matin M Imanguli
    Clinical Research Core, National Institutes of Health, Bethesda, MD 20892, USA
    Exp Hematol 35:184-92. 2007
    ..This study was an initial evaluation of salivary protein changes that occur after allo-HCT...